Skip to content
healthcare.dev

Epclusa

NDC 61958-2204, Velpatasvir and Sofosbuvir, pellet, from Gilead Sciences, Inc..

Product NDC
61958-2204
Status
Listed
Labeler
Gilead Sciences, Inc.
Dosage form
PELLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214187
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61958-2204 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VELPATASVIR50 mg/1
  • SOFOSBUVIR200 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Hepatitis C Virus NS5A Inhibitor [EPC]; Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]; Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]; Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; RNA Replicase Inhibitors [MoA]

Package NDCNDC-11Package
61958-2204-16195822040128 PACKET in 1 CARTON (61958-2204-1) / 1 PELLET in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7f30631a-ee3b-4cfe-866b-964df3f0a44f

Use it

Look up 61958-2204 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61958-2204 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61958-2204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.